PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11015294-3	2000	In N1E-115 neuroblastoma cells endogenously expressing the M(1) and M(4) receptor subtypes, MT-7 (0.3 - 3.0 nM) inhibited the carbachol (CCh)-stimulated inositol phosphates accumulation, but failed to affect the CCh-induced inhibition of pituitary adenylate cyclase activating polypeptide (PACAP) 38-stimulated cyclic AMP accumulation.	Carbachol	126-135	adenylate cyclase activating polypeptide 1	Mus musculus	290-295	
1423494-8	1992	Furthermore, PACAP-38 (7 nmol/kg) potentiated the plasma glucagon response to the cholinergic agonist carbachol (0.16 mumol/kg).	Carbachol	102-111	adenylate cyclase activating polypeptide 1	Mus musculus	13-18	
1423494-10	1992	Moreover, PACAP-38 inhibited a carbachol-induced increase in the level of plasma insulin in the absence but not in the presence of adrenergic blockade.	Carbachol	31-40	adenylate cyclase activating polypeptide 1	Mus musculus	10-15	
1423494-12	1992	We conclude that PACAP-like immunoreactivity exists in nerve fibers innervating the mouse and rat pancreas, particularly the intrapancreatic ganglia, and that PACAP-38 augments both basal and carbachol-stimulated glucagon secretion in the mouse.	Carbachol	192-201	adenylate cyclase activating polypeptide 1	Mus musculus	159-164	
11015294-3	2000	In N1E-115 neuroblastoma cells endogenously expressing the M(1) and M(4) receptor subtypes, MT-7 (0.3 - 3.0 nM) inhibited the carbachol (CCh)-stimulated inositol phosphates accumulation, but failed to affect the CCh-induced inhibition of pituitary adenylate cyclase activating polypeptide (PACAP) 38-stimulated cyclic AMP accumulation.	Carbachol	137-140	adenylate cyclase activating polypeptide 1	Mus musculus	290-295